Evaluation of Peripheral Blood Markers as Early Endpoint Criteria in Guinea Pigs (Cavia porcellus) when Testing Tuberculosis Vaccine Candidates
Document Type: Research Article
Affiliations: 1: Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma;, Email: [email protected] 2: Departments of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado 3: University of Queensland, Australian Infectious Diseases Research Centre, St Lucia, and School of Veterinary Science, Gatton Campus, Queensland, Australia 4: Department of Clinical Sciences, Colorado State University, Fort Collins, Colorado
Publication date: February 1, 2020
This article was made available online on January 17, 2020 as a Fast Track article with title: "Evaluation of Peripheral Blood Markers as Early Endpoint Criteria in Guinea Pigs (Cavia porcellus) when Testing Tuberculosis Vaccine Candidates".
Comparative Medicine (CM), an international journal of comparative and experimental medicine, is the leading English-language publication in the field and is ranked by the Science Citation Index in the upper third of all scientific journals. The mission of CM is to disseminate high-quality, peer-reviewed information that expands biomedical knowledge and promotes human and animal health through the study of laboratory animal disease, animal models of disease, and basic biologic mechanisms related to disease in people and animals.
Attention Members: To access the full text of the articles, be sure you are logged in to the AALAS website.
Attention: please note, due to a temporary technical problem, reference linking within the content is not available at this time
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- For issues prior to 1998
- Institutional Subscription Activation
- Ingenta Connect is not responsible for the content or availability of external websites